Researchers can utilize our supercomputer for conducting research in the field of personalised medicine. Through a customized DNGC Cloud, they can leverage the supercomputer's storage capacity and computing power. The supercomputer can accommodate large amounts of data and perform advanced analyses, which researchers can use to gain a better understanding of diseases and develop new treatment methods.
Led by principal investigator, professor, and center director Tine Jess
Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT) is a national research center of excellence where researchers develop strategies for personalised medicine for patients with inflammatory bowel diseases.
Led by Principal investigator, professor in pediatrics, Dr. Kjeld Schmiegelow
ICOPE/STAGING is a prospective study where, over the course of several years, researchers have collected data from 1,200 children with cancer. The purpose is to understand rare variants and to identify new cancer predisposition genes.
Led by Principal Investigator, research director, professor Søren Brunak
The researchers are examining patient trajectories within various disease areas. The aim is to estimate how the course of a patient's illness will unfold and use that knowledge to potentially treat patients differently.
Led by Principal Investigator, professor, chief physician Lone Skov
BIOSKIN focuses on inflammatory skin diseases such as psoriasis, atopic dermatitis, and contact eczema. The purpose is to gather knowledge about how skin diseases develop over time, so that in the future, we can offer more individualized treatment.
Led by Principal Investigator Professor Rikke Steensbjerre Møller
The purpose of the research is to provide genetic counseling and develop personalised treatment approaches for epilepsy, ultimately aiming to tailor patients' epilepsy medication to their genetic profile.
Led by Principal Investigator, Chief Physician Melinda Magyari
The purpose of the research is to develop tailored treatments for patients with multiple sclerosis. Using artificial intelligence, researchers identify how patients experience different disease trajectories.
Led by Principal Investigator, Consultant, Clinical Associate Professor Mette Damkjær Bartels
The departments of clinical microbiology at Amager and Hvidovre Hospital and Herlev and Gentofte Hospital, perform whole genome sequencing on pathogenic microorganisms. The data are used in both daily clinical work and research.
@0,5x.png?crop=0%2c0%2c1005%2c1005&width=960){kind=spacer}
Led by Principal Investigator, consultant, and clinical lecturer Carsten Utoft Niemann
DALY-CARE focuses on data-driven treatment of lymphoproliferative cancer diseases. The aim is to personalize the treatment of patients by analyzing patient factors and disease characteristics together with molecular and genetic information.